In The Descent, an outdoor adventure goes terribly wrong for six friends who enter caves looking for fun but find murderous creatures within the depths. Jen Karner has spent the last 10 years covering ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The recursion depth limit in the descriptor parser is enforced after the full parse has already completed, which defeats its protective purpose. Specifically, the check is performed only after parser: ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

I'm two for two on writing about games set on the moon today, but sometimes that's just how it is! This time around it's about a newly revealed game called Descent of Lunaris, a dungeon-crawling, turn ...

Players aren’t simply fighting to survive another descent, they’re unraveling a mystery that asks difficult questions about the nature of humanity itself. Every floor deepens the uncertainty: are you ...